• Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Leu1061Pro (c.3182T>C); ClinVar=VCV000134079; Zygosity=Unspecified (PubMed=26919099).
  
• Mutation; HGNC; HGNC:3430; ERBB2; Simple; p.Pro1170Ala (c.3508C>G); ClinVar=VCV000134082; Zygosity=Unspecified (PubMed=26919099).
  
• Mutation; HGNC; HGNC:3431; ERBB3; Simple; p.Thr757Lys (c.2270C>A); Zygosity=Unspecified (PubMed=26919099).
  
• Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg282Trp (c.844C>T); ClinVar=VCV000012364; Zygosity=Unspecified (PubMed=10841287).
  

PubMed=9723033; DOI=10.1016/S0165-4608(98)00023-5
Bertoni L., Zoli W., Mucciolo E., Ricotti L., Nergadze S., Amadori D., Giulotto E.
Different genome organization in two new cell lines established from human gastric carcinoma.
Cancer Genet. Cytogenet. 105:152-159(1998)

PubMed=10841287
Calistri D., Barzanti F., Dal Susino M., Fedriga R., Saragoni L., Bernardi L., Ricotti L., Zoli W.
Correlation between p53 gene mutations and p53 protein accumulation evaluated by different methodologies.
J. Biol. Regul. Homeost. Agents 14:120-127(2000)

PubMed=26919099; DOI=10.18632/oncotarget.7575; PMCID=PMC4951299
Arienti C., Zanoni M., Pignatta S., Del Rio A., Carloni S., Tebaldi M., Tedaldi G., Tesei A.
Preclinical evidence of multiple mechanisms underlying trastuzumab resistance in gastric cancer.
Oncotarget 7:18424-18439(2016)